OneSource Specialty Pharma Allots 36,065 Equity Shares Under ESOP 2021 to Eligible Employees

1 min read | Published on 21 Jan 2026, 06:40 PM |Updated on 21 Jan 2026, 06:40 PM

Reviewed by

Ashish TScanX News Team

Key Highlights

OneSource Specialty Pharma Limited allotted 36,065 equity shares under ESOP 2021 to eligible employees on January 21, 2026, at ₹278.00 per share. The allotment increased the company's paid-up share capital to ₹11.46 crores, with total equity shares reaching 11,46,21,201. The newly issued shares rank pari passu with existing shares and carry no lock-in restrictions.

*this image is generated using AI for illustrative purposes only.

OneSource Specialty Pharma Limited has successfully allotted 36,065 equity shares under its Employee Stock Option Plan 2021 to eligible employees. The Management Committee approved this allotment during its meeting held on January 21, 2026, marking another milestone in the company's employee incentive program.

Share Allotment Details

The allotment was executed under the OneSource Specialty Pharma Limited – Employee Stock Option Plan 2021 (ONESOURCE ESOP 2021), with employees exercising their vested options. The key parameters of this allotment are presented below:

Parameter	Details
Number of Shares Allotted	36,065
Par Value per Share	₹1.00
Exercise Price per Share	₹278.00
Premium per Share	₹277.00
Date of Allotment	January 21, 2026
ISIN Number	INE013P01021

Impact on Share Capital Structure

The allotment has resulted in an expansion of the company's equity base. The paid-up share capital witnessed an increase following the incorporation of these new shares:

Metric	Before Allotment	After Allotment
Total Equity Shares	11,45,85,136	11,46,21,201
Paid-up Share Capital	₹11,45,85,136	₹11,46,21,201
Distinctive Numbers	-	125674457 to 125710521

Regulatory Compliance and Share Characteristics

The allotment was conducted in full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company had previously filed the required statement under Regulation 10(b) with stock exchanges on March 12, 2025.

The newly allotted equity shares carry the following characteristics:

Rank pari passu with existing equity shares in all respects
No lock-in restrictions applicable
Identical to existing shares in terms of rights and privileges
Listed on BSE Limited and National Stock Exchange of India Limited

Corporate Governance Framework

The allotment process was overseen by the Management Committee and executed under the supervision of Company Secretary and Compliance Officer Trisha A (Membership Number: A47635). The company maintains its registered office at Unit No. 902, "Cyber One", Plot No - 4 & 6, Sector 30A, Vashi, Navi Mumbai 400703, ensuring proper governance standards throughout the process.

This ESOP allotment reflects OneSource Specialty Pharma's commitment to employee participation in the company's growth story while maintaining strict adherence to regulatory requirements and corporate governance practices.

Historical Stock Returns for Onesource Specialty Pharma